While the U.S. did very well on the scientific front of Covid-19 with the production of vaccines, it needs to improve on the public health front, said Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases. He made these comments Tuesday at the AHIP 2023 conference in Portland.
Dr. Fauci stressed that whether humanity can root out the novel coronavirus depends on whether a robust global vaccine campaign can be launched such that cheaper and easily deliverable vaccines can be distributed en masse.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Here is our attempt to capture this bewildering and memorable year by highlighting the phenomena and personalities who made it so.
A health journalist, a physician and a former foreign correspondent sits down with Dr. Anthony Fauci for a lengthy Q&A about safety during Covid times.
The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.
In a wide-ranging interview for BIO's virtual annual meeting with the trade and lobbying group's president, NIAID Director Anthony Fauci also said "good-faith" discussions are important to avoiding excessive pricing and ensuring affordability and access.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.